Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of acombined recombinant MVA/DNA vaccination scheme

Huemer HP.; Strobl B.; Nowotny N.

首页> 外文期刊>Vaccine >Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of acombined recombinant MVA/DNA vaccination scheme

【24h】

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of acombined recombinant MVA/DNA vaccination scheme

机译：表达EHV-1 gC的无源牛痘病毒MVA作为重组MVA / DNA联合疫苗接种计划的基础

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The nonreplicating chicken adapted vaccinia virus strain MVA was used in a combined vaccine scheme. Using the equine herpesvirus type 1 (EHV-1) encoded complement-receptor glycoprotein C as antigen, only poor antibody response was induced by exclusive vaccination with DNA plasmids. The administration of recombinant MVA followed by plasmid immunization elicited both humoral and cellular immune responses in hamster comparable to EHV-1 full virus vaccines.

机译：非复制型鸡适应痘苗病毒株MVA用于联合疫苗方案。使用1型马疱疹病毒（EHV-1）编码的补体受体糖蛋白C作为抗原，通过仅接种DNA质粒仅诱导较差的抗体反应。与EHV-1全病毒疫苗相比，重组MVA的给药以及质粒免疫引起仓鼠的体液和细胞免疫应答。

著录项

来源
《Vaccine》 |2000年第14期|共7页
作者
Huemer HP.; Strobl B.; Nowotny N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类卫生标准、卫生检查、医药管理;
关键词
Vaccinia virus; Mva; Dna vaccine; Ehv; Equine herpesvirus-1; Glycoprotein-c; Dna vaccination; Responses; Proteins; Disease; Strains; Horses; Cells; Mice;

机译：牛痘病毒;Mva;Dna疫苗;Ehv;Equine疱疹病毒-1;糖蛋白c;Dna疫苗接种;反应;蛋白质;疾病;菌株;马;细胞;小鼠;

相似文献

外文文献
中文文献
专利

1. Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of acombined recombinant MVA/DNA vaccination scheme [J] . Huemer HP., Strobl B., Nowotny N. Vaccine . 2000,第14期

机译：表达EHV-1 gC的无源牛痘病毒MVA作为重组MVA / DNA联合疫苗接种计划的基础
2. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination [J] . Vaccine . 2017,第44期

机译：用重组改性的痘苗病毒疫苗接种疫苗（MVA）病毒表达单一非洲马疾病病毒VP2抗原诱导在组合施用时诱导马匹的交叉反应性病毒中和抗体（VNAB）
3. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. [J] . Alberca B., Bachanek-Bankowska K., Cabana M., Vaccine . 2014,第29期

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）接种马匹，可提供针对挑战的完整临床保护。
4. Prime boost vaccination with pSG2 plasmid and MVA each recombinant for a MAP fusion protein attenuates pre-existing MAP infection in C57/BL6 mice [C] . Bull TJ, Sidi-Boumedine S, Cen-Si, International Colloquium on Paratuberculosis . 2007

机译：用PSG2质粒和MVA的初始促进疫苗接种，每种重组地图融合蛋白在C57 / BL6小鼠中衰减预先存在的地图感染
5. Comparison of murine B7-1 and B7-2 in generating an anti-tumor immune response when delivered by recombinant vaccinia virus vaccination. [D] . Beckerleg, Anne Marie Sabrina. 2002

机译：当通过重组牛痘病毒疫苗接种时，鼠B7-1和B7-2在产生抗肿瘤免疫应答中的比较。
6. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge [O] . Berta Alberca, Katarzyna Bachanek-Bankowska, Marta Cabana, -1

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）接种马匹可提供针对挑战的完整临床保护
7. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge [O] . Alberca Berta, Bachanek-Bankowska Katarzyna, Cabana Marta, 2014

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）进行马匹疫苗接种，可提供针对挑战的完整临床保护
8. Evaluation of the Efficacy of Modified Vaccinia Ankara (MVA)/IMVAMUNE (registered trademark) Against Aerosolized Rabbitpox Virus in a Rabbit Model [R] . Garza, N. L., Hatkin, J. M., Livingston, V., 2009

机译：改良痘苗剂安卡拉（mVa）/ ImVamUNE（注册商标）对兔模型气雾化兔痘病毒的疗效评价

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of acombined recombinant MVA/DNA vaccination scheme

摘要

著录项

相似文献

相关主题

期刊订阅